Pathological Left Ventricular Hypertrophy and Stem Cells: Current Evidence and New Perspectives

Area of Science:

• Cardiovascular Biology
• Regenerative Medicine
• Cardiac Pathophysiology

Background:

• Left ventricular hypertrophy (LVH) predicts adverse cardiovascular outcomes.
• LVH involves increased protein synthesis, cell size, and progenitor cell activity.
• Stem and progenitor cells aid cardiomyocyte renewal after cardiac injury or overload.

Purpose of the Study:

• To explore the role of stem and progenitor cells in LVH.
• To investigate their contribution to myocardial repair and remodeling.
• To assess their potential for regenerative cell therapy.

Main Methods:

• Review of existing literature on stem/progenitor cells in cardiac hypertrophy.
• Analysis of cellular mechanisms involved in LVH.
• Exploration of cell mobilization and differentiation pathways.

Main Results:

• Stem and progenitor cells are activated in LVH, contributing to cardiomyocyte renewal.
• These cells secrete factors crucial for cardiac remodeling and neovascularization.
• Epicardial progenitor cells migrate to the myocardium, participating in cardiac structure formation.
• Cell mobilization is triggered by mechanical, chemical, hormonal, or pharmacological stimuli.

Conclusions:

• Stem and progenitor cells play a significant regulatory role in myocardial repair during LVH.
• Their regenerative potential offers promise for therapeutic interventions against adverse cardiac remodeling.
• Further research is needed to fully elucidate the underlying pathophysiological mechanisms.